Mark Hoppus Shows Hair Regrowth, Says He Feels 'Terrible' After Chemotherapy

Blink-182 musician Mark Hoppus has shared a health update with his fans, after undergoing chemotherapy for blood cancer.

The bassist and singer, 49, announced in June that he had cancer and had been undergoing chemotherapy over the previous three months. He then shared in July that he was battling Stage IV blood cancer.

On Tuesday, Hoppus took to Instagram to post a photo of his stubble-covered head as he spoke about his hair growing back following his treatment, while also admitting that he felt "terrible" amid his bout with the disease.

Taking an upbeat approach to his residual effects of his treatment, the star wrote: "Hahaha. Look at this trash. This is the top of my head right now. This is what God sees when He looks down upon His work and despairs. Cancer-a** head trying to grow back some hair. Awww. Poor little head. Keep your chin up, fighter."

"Feeling terrible this week but trying to stay positive and count my blessings," he continued. "I hope everyone is doing great, staying healthy, and being kind to each other. If anyone needs me, I'll be on the couch for the foreseeable future."

Blink-182 star Mark Hoppus
Mark Hoppus attends the Opening reception for Michael Muller's Book "Shark" hosted by TASCHEN at TASCHEN Gallery on April 26, 2016 in Los Angeles, California. The Blink-182 musician revealed earlier this summer that he was... Matt Winkelmeyer/Getty Images

On June 23, Hoppus revealed his cancer diagnosis in a Twitter post that read: "For the past three months I've been undergoing chemotherapy for cancer.

"I have cancer. It sucks and I'm scared, and at the same time I'm blessed with incredible doctors and family and friends to get me through this.

"I still have months of treatment ahead of me but I'm trying to remain hopeful and positive. Can't wait to be cancer free and see you all at a concert in the near future. Love to you all."

Soon after the post was shared, his Blink-182 bandmate Travis Barker told E! News: "Mark is my brother and I love and support him. I will be with him every step of the way on stage and off and can't wait for us to play together again soon."

Tom DeLonge, former Blink-182 frontman, wrote on Twitter at the time: "I too, have been aware of @markhoppus's cancer diagnosis for awhile now.

"And to add to his own words that he used today, I would also like to say that he is strong, and a super-human who is pushing through this difficult obstacle with a wide-open heart. 👊🏼#WeHaveHisBack."

During a Twitch live stream in July, Hoppus shared further information on his cancer.

"The cancer isn't bone-related, it's blood-related. My blood's trying to kill me," he was quoted as saying. "My classification is diffuse large B-cell lymphoma Stage IV-A, which means, as I understand it, it's entered four parts of my body.

"I don't know how exactly they determine the four-part of it, but it's entered enough parts of my body that I'm Stage IV, which I think is the highest that it goes. So, I'm Stage IV-A."

The members of Blink-182
(L-R) Matt Skiba, Mark Hoppus and Travis Barker of the band Blink-182 attend iHeartRadio ALTer EGO presented by Capital One at The Forum on January 18, 2020 in Inglewood, California. JC Olivera/Getty Images

Uncommon Knowledge

Newsweek is committed to challenging conventional wisdom and finding connections in the search for common ground.

Newsweek is committed to challenging conventional wisdom and finding connections in the search for common ground.

About the writer


Ryan Smith is a Newsweek Senior Pop Culture and Entertainment Reporter based in London, U.K. His focus is reporting on ... Read more

To read how Newsweek uses AI as a newsroom tool, Click here.

Newsweek cover
  • Newsweek magazine delivered to your door
  • Newsweek Voices: Diverse audio opinions
  • Enjoy ad-free browsing on Newsweek.com
  • Comment on articles
  • Newsweek app updates on-the-go
Newsweek cover
  • Newsweek Voices: Diverse audio opinions
  • Enjoy ad-free browsing on Newsweek.com
  • Comment on articles
  • Newsweek app updates on-the-go